Close Menu

NEW YORK (GenomeWeb) – OpGen announced today that it has closed its previously announced public offering, raising $12 million in gross proceeds.

The offering comprised about 2.8 million units at $3.25 per unit, and 851,155 pre-funded units at $3.24 per-refunded unit.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.